Board’s specialties in rare diseases, oncology, neurosciences, cardiology and metabolic disorders drive Kayentis’ expertise ...

Following this acquisition, Titterton's direct ownership in Anixa Biosciences (NASDAQ:ANIX) stands at 922,334 shares. The ...

PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) has announced the appointment of Andy Pasternak as Chairman of ...

"I'm really excited to see how we're going to be able to use that money to impact families in Baltimore City positively," ...

Equitable Holdings, Inc. (NYSE: EQH) today announced the appointment of Douglas Dachille as an independent member of its Board of Directors, effective immediately.

Triplebar, a pioneering biotechnology company based in Emeryville which is focused on developing cost effective and effective ...

Launching a private equity fund is an exciting yet daunting endeavor; and a General Partner (GP) Advisory Board can be a ...

About 100 New Orleans high school students are taking part in the only open-enrollment, three-year culinary program in the ...

Mr. Pasternak brings decades of global pharmaceutical leadership experience ...

Estimated 54 million people suffer from obstructive sleep apnea in the U.S. including 30-50% of adults with hypertension, both conditions ...

Jan. 15, 2025 — Scientists have come up with a drug that is a potential candidate for tackling memory deficits in the early stages of the disease in rodents. Research shows that the drug ...